Skip to main content

Table 3 Number and percentage of adult CF people in the category of CFTR mutation, nutritional status, lung function, and Pseudomonas aeruginosa infection

From: The determinants of survival among adults with cystic fibrosis—a cohort study

Variable Number N (%)
Genotype
 I–III/I–III 40 32.26
 I–III/IV–V or I–III/u 31 25.00
 IV–V/IV–V 24 19.35
 u/u 29 23.39
FEV1%
 FEV1% > 70 31 25.00
 FEV1% 70–40 47 37.90
 FEV1% < 40 46 37.10
Pseudomonas aeruginosa
Pseudomonas culture-negative 36 29.03
 Non-MDR 37 29.84
 MDR 24 19.36
 XDR/PDR 27 21.77
Nutritional status
 BMI ≥ 25 5 4.03
 BMI 18.5–24.9 74 59.68
 BMI 17–18.49 (class II malnutrition) 24 19.35
 BMI 16–16.99 (class I malnutrition) 9 7.26
 BMI < 16 (emaciation) 12 9.68
  1. I–III/I–III patients with severe types of mutation on both alleles, I–III/IV–V or I–III/u patients with a severe type of mutation on one allele and mild or unclassified mutation on another allele, IV–V/IV–V patients with mild types of mutation on both alleles, u/u patients with unclassified mutations on both alleles, BMI body mass index, FEV1% forced expiratory volume in one second, Non-MDR non-multidrug-resistant patients, MDR multidrug-resistant patients, PDR+XDR pandrug-resistant and extensively drug-resistant patients